Mereo BioPharma Group plc - Ordinary Shares (MREO)

CUSIP: 589492107

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Ordinary Shares
Shares outstanding
795,765,179
Total 13F shares
87,544,301
Share change
-2,099,055
Total reported value
$211,861,957
Put/Call ratio
145%
Price per share
$2.42
Number of holders
58
Value change
-$26,671,615
Number of buys
24
Number of sells
36

Security key

589492107

Report period

Q3 2021

Institutions

58

Top holders

10

Top shareholders of MREO - Mereo BioPharma Group plc - Ordinary Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Point72 Asset Management, L.P.
13F
Company
1.3%
10,107,189
$32,040,000 30 Jun 2021
13F
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
1.1%
8,649,300
$27,418,000 30 Jun 2021
13F
Boxer Capital, LLC
13F
Company
0.78%
6,226,673
$19,739,000 30 Jun 2021
13F
Rubric Capital Management LP
13F
Company
0.71%
5,660,608
$17,944,000 30 Jun 2021
13F
Rock Springs Capital Management LP
13F
Company
0.57%
4,542,769
$14,401,000 30 Jun 2021
13F
Vivo Capital, LLC
13F
Company
0.53%
4,220,938
$13,380,000 30 Jun 2021
13F
HHLR ADVISORS, LTD.
13F
Company
0.37%
2,976,121
$9,434,000 30 Jun 2021
13F
CITADEL ADVISORS LLC
13F
Company
0.37%
2,954,068
$9,364,000 30 Jun 2021
13F
BAKER BROS. ADVISORS LP
13F
Company
0.31%
2,459,399
$7,796,000 30 Jun 2021
13F
Commodore Capital LP
13F
Company
0.26%
2,059,729
$6,529,000 30 Jun 2021
13F
Holocene Advisors, LP
13F
Company
0.25%
1,949,737
$6,181,000 30 Jun 2021
13F
ALKEON CAPITAL MANAGEMENT LLC
13F
Company
0.24%
1,935,600
$6,136,000 30 Jun 2021
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.21%
1,696,068
$5,377,000 30 Jun 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.21%
1,663,950
$5,275,000 30 Jun 2021
13F
Asymmetry Capital Management, L.P.
13F
Company
0.2%
1,618,328
$5,130,000 30 Jun 2021
13F
Artal Group S.A.
13F
Company
0.19%
1,500,000
$4,755,000 30 Jun 2021
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.17%
1,325,053
$4,200,000 30 Jun 2021
13F
Tri Locum Partners LP
13F
Company
0.16%
1,253,729
$3,974,000 30 Jun 2021
13F
Altium Capital Management LLC
13F
Company
0.16%
1,250,000
$3,963,000 30 Jun 2021
13F
DAFNA Capital Management LLC
13F
Company
0.14%
1,126,613
$3,571,000 30 Jun 2021
13F
Tekla Capital Management LLC
13F
Company
0.13%
1,044,790
$3,312,000 30 Jun 2021
13F
Ikarian Capital, LLC
13F
Company
0.12%
944,308
$346,000 30 Jun 2021
13F
Monashee Investment Management LLC
13F
Company
0.1%
800,000
$2,536,000 30 Jun 2021
13F
Endurant Capital Management LP
13F
Company
0.1%
756,915
$2,399,000 30 Jun 2021
13F
Affinity Asset Advisors, LLC
13F
Company
0.08%
650,000
$2,061,000 30 Jun 2021
13F
J. Goldman & Co LP
13F
Company
0.08%
626,421
$1,986,000 30 Jun 2021
13F
PRIMECAP MANAGEMENT CO/CA/
13F
Company
0.06%
488,938
$1,550,000 30 Jun 2021
13F
SILVERARC CAPITAL MANAGEMENT, LLC
13F
Company
0.05%
405,871
$1,287,000 30 Jun 2021
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.04%
285,100
$904,000 30 Jun 2021
13F
Atom Investors LP
13F
Company
0.03%
269,390
$854,000 30 Jun 2021
13F
Delphi Management Partners VIII, L.L.C.
13F
Company
0.03%
256,734
$814,000 30 Jun 2021
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
0.02%
196,570
$623,000 30 Jun 2021
13F
Insight Advisors, LLC/ PA
13F
Company
0.02%
165,825
$438,000 30 Jun 2021
13F
Jump Financial, LLC
13F
Company
0.02%
151,700
$481,000 30 Jun 2021
13F
HealthCor Management, L.P.
13F
Company
0.02%
149,170
$473,000 30 Jun 2021
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.02%
128,048
$406,000 30 Jun 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.01%
96,630
$306,000 30 Jun 2021
13F
STATE STREET CORP
13F
Company
0.01%
78,200
$248,000 30 Jun 2021
13F
HSBC HOLDINGS PLC
13F
Company
0.01%
58,217
$180,000 30 Jun 2021
13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC
13F
Company
0.01%
58,200
$184,000 30 Jun 2021
13F
BESSEMER GROUP INC
13F
Company
0.01%
58,000
$184,000 30 Jun 2021
13F
MORGAN STANLEY
13F
Company
0.01%
55,591
$177,000 30 Jun 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.01%
54,433
$173,000 30 Jun 2021
13F
Logos Global Management LP
13F
Company
0.01%
46,984
$149,000 30 Jun 2021
13F
MARSHALL WACE, LLP
13F
Company
0.01%
44,682
$142,000 30 Jun 2021
13F
PERSONAL CFO SOLUTIONS, LLC
13F
Company
0%
33,388
$106,000 30 Jun 2021
13F
Valeo Financial Advisors, LLC
13F
Company
0%
32,506
$103,000 30 Jun 2021
13F
Man Group plc
13F
Company
0%
27,400
$87,000 30 Jun 2021
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0%
21,129
$67,000 30 Jun 2021
13F
BARCLAYS PLC
13F
Company
0%
20,000
$63,000 30 Jun 2021
13F

Institutional Holders of Mereo BioPharma Group plc - Ordinary Shares (MREO) as of Q3 2021

As of 30 Sep 2021, Mereo BioPharma Group plc - Ordinary Shares (MREO) was held by 58 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 87,544,301 shares. The largest 10 holders included ORBIMED ADVISORS LLC, Rubric Capital Management LP, Point72 Asset Management, L.P., SUVRETTA CAPITAL MANAGEMENT, LLC, Vivo Capital, LLC, Rock Springs Capital Management LP, CITADEL ADVISORS LLC, HHLR ADVISORS, LTD., Holocene Advisors, LP, and COMMODORE CAPITAL LP. This page lists 58 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders
68
Q3 2021 holders
58
Holder diff
-10
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 Value $ Q3 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .